Literature DB >> 21301070

The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.

David Basanta1, Jacob G Scott, Russ Rockne, Kristin R Swanson, Alexander R A Anderson.   

Abstract

Recent advances in clinical medicine have elucidated two significantly different subtypes of glioblastoma which carry very different prognoses, both defined by mutations in isocitrate dehydrogenase-1 (IDH-1). The mechanistic consequences of this mutation have not yet been fully clarified, with conflicting opinions existing in the literature; however, IDH-1 mutation may be used as a surrogate marker to distinguish between primary and secondary glioblastoma multiforme (sGBM) from malignant progression of a lower grade glioma. We develop a mathematical model of IDH-1 mutated secondary glioblastoma using evolutionary game theory to investigate the interactions between four different phenotypic populations within the tumor: autonomous growth, invasive, glycolytic, and the hybrid invasive/glycolytic cells. Our model recapitulates glioblastoma behavior well and is able to reproduce two recent experimental findings, as well as make novel predictions concerning the rate of invasive growth as a function of vascularity, and fluctuations in the proportions of phenotypic populations that a glioblastoma will experience under different microenvironmental constraints.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301070      PMCID: PMC3166886          DOI: 10.1088/1478-3975/8/1/015016

Source DB:  PubMed          Journal:  Phys Biol        ISSN: 1478-3967            Impact factor:   2.583


  27 in total

1.  Evolutionary game theory.

Authors:  K Sigmund; M A Nowak
Journal:  Curr Biol       Date:  1999-07-15       Impact factor: 10.834

Review 2.  Rules for making human tumor cells.

Authors:  William C Hahn; Robert A Weinberg
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

3.  Mathematical oncology: cancer summed up.

Authors:  Robert A Gatenby; Philip K Maini
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

4.  The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice.

Authors:  Y MATSUKADO; C S MACCARTY; J W KERNOHAN
Journal:  J Neurosurg       Date:  1961-09       Impact factor: 5.115

5.  Dichotomy of astrocytoma migration and proliferation.

Authors:  A Giese; M A Loo; N Tran; D Haskett; S W Coons; M E Berens
Journal:  Int J Cancer       Date:  1996-07-17       Impact factor: 7.396

6.  A quantitative model for differential motility of gliomas in grey and white matter.

Authors:  K R Swanson; E C Alvord; J D Murray
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.

Authors:  Robert A Gatenby; Edward T Gawlinski
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

Review 9.  Cost of migration: invasion of malignant gliomas and implications for treatment.

Authors:  A Giese; R Bjerkvig; M E Berens; M Westphal
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

10.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2010-06-17       Impact factor: 69.504

View more
  21 in total

1.  Edge effects in game-theoretic dynamics of spatially structured tumours.

Authors:  Artem Kaznatcheev; Jacob G Scott; David Basanta
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

2.  Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift?

Authors:  Jacob G Scott; David Basanta; Prakash Chinnaiyan; Peter Canoll; Kristen R Swanson; Alexander R A Anderson
Journal:  Neuro Oncol       Date:  2011-07-22       Impact factor: 12.300

3.  Exploiting evolution to treat drug resistance: combination therapy and the double bind.

Authors:  David Basanta; Robert A Gatenby; Alexander R A Anderson
Journal:  Mol Pharm       Date:  2012-03-19       Impact factor: 4.939

4.  Malignancy through cooperation: an evolutionary game theory approach.

Authors:  Q Liu; Z Liu
Journal:  Cell Prolif       Date:  2012-05-18       Impact factor: 6.831

5.  Game theory in the death galaxy: interaction of cancer and stromal cells in tumour microenvironment.

Authors:  Amy Wu; David Liao; Thea D Tlsty; James C Sturm; Robert H Austin
Journal:  Interface Focus       Date:  2014-08-06       Impact factor: 3.906

Review 6.  Exploiting ecological principles to better understand cancer progression and treatment.

Authors:  David Basanta; Alexander R A Anderson
Journal:  Interface Focus       Date:  2013-08-06       Impact factor: 3.906

7.  Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

Authors:  Anne L Baldock; Kevin Yagle; Donald E Born; Sunyoung Ahn; Andrew D Trister; Maxwell Neal; Sandra K Johnston; Carly A Bridge; David Basanta; Jacob Scott; Hani Malone; Adam M Sonabend; Peter Canoll; Maciej M Mrugala; Jason K Rockhill; Russell C Rockne; Kristin R Swanson
Journal:  Neuro Oncol       Date:  2014-06       Impact factor: 12.300

8.  Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.

Authors:  Homan Mohammadi; Kevin Shiue; G Daniel Grass; Vivek Verma; Kay Engellandt; Dirk Daubner; Gabriele Schackert; Mercia J Gondim; Dibson Gondim; Alexander O Vortmeyer; Aaron P Kamer; William Jin; Timothy J Robinson; Gordon Watson; Hsiang-Hsuan M Yu; Tim Lautenschlaeger
Journal:  Neurooncol Pract       Date:  2019-10-10

9.  Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game.

Authors:  D Basanta; J G Scott; M N Fishman; G Ayala; S W Hayward; A R A Anderson
Journal:  Br J Cancer       Date:  2011-12-01       Impact factor: 7.640

10.  Cancer immunoediting: A game theoretical approach.

Authors:  Fatemeh Tavakoli; Javad Salimi Sartakhti; Mohammad Hossein Manshaei; David Basanta
Journal:  In Silico Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.